May 6, 2015

A newly designed plastic stent for EUS-guided hepaticogastrostomy: a prospective preliminary feasibility study (with videos)

Gastrointestinal Endoscopy
Junko UmedaFuminori Moriyasu


There are currently no dedicated plastic stents for EUS-guided hepaticogastrostomy (EUS-HGS). We prospectively evaluated the feasibility and the technical and functional success rates of our newly designed plastic stent for EUS-HGS. Prospective preliminary feasibility study. A tertiary-care referral center. Twenty-three consecutive patients were treated. The reasons for requiring EUS-HGS were periampullary tumor invasion (n=9), altered anatomy (n=7), failed duodenal intubation (n=3), and previous ERCP failure (n=4). An 8F single-pigtail plastic stent with 4 flanges was placed for EUS-HGS. Technical success, clinical success, and adverse events according to the American Society for Gastrointestinal Endoscopy lexicon. All stents were successfully deployed without procedural adverse events (100% technical success rate). Bleeding from the punctured gastric wall occurred in 1 patient 3 days postoperatively. We exchanged the plastic stent for a fully covered self-expandable metal stent. A mild adverse event of self-limited abdominal pain occurred in 3 patients. Treatment success was achieved in all patients. The occlusion rate was 13.7% (3/22) during the median follow-up period (5.0 months, range 0.5-12.5 months). The median duration...Continue Reading

Mentioned in this Paper

Endoscopy, Gastrointestinal
Endoscopy (Procedure)
Anatomic Structures
Abdominal Pain
Tertiary Care Centers
Stent, Device
Incidence Studies

Related Feeds

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.